Learn how the molecule EBC-46 could advance how HIV is treated and how researchers discovered it.

The first known case of HIV-1 infection in human was detected in 1959, from a blood sample of a man in Kinshasa, Democratic ...

Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more vulnerable to diseases and infections. Once inside human cells ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating HIV. Acting as a potent latency-reversing agent, EBC-46 activates dormant ...

HIV-1, like other viruses, lacks the machinery to produce its own proteins and must rely on the host cell to translate its genetic instructions. After entering host cells, it seizes control of the ...

Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my ...